Physician profile
Samuel E Cohen
NPI 1366700700
$5,807.37
in general payments reported to CMS, 2019-2025
9 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2021: $3,613 · 2022: $83.36 · 2023: $253 · 2024: $1,417 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,125 · Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,124.94 |
| Food and Beverage | $746.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,444.93 | 2021 | |
| Pulmonx Corporation | $1,527.02 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.00 | 2019-2021 | |
| Vapotherm INC | $146.50 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $128.14 | 2024 | Terlivaz |
| Olympus America INC. | $117.02 | 2025 | Spiration Valve System |
| Coaptech, INC. | $103.16 | 2022-2025 | Puma System, Puma System |
| Boston Scientific Corporation | $47.62 | 2022-2023 | Exalt Model D |
| Abbvie INC. | $42.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$60,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.